Chemical Probes logo
AVL-292 | AVL-292 : Covalent inhibitor of BTK
RATINGS:
Cellular Use: (3 reviews)

In Model Organisms: (2 reviews)
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
BTK
  • Kinact/KI:7.69 x 10^4 per M per sec
  • EC50:8 nM
Covalent Inhibitor
Up to 100 nM

Selectivity

In Vitro Selectivity Assessment

Potency: IC50(app) - BMX 0.7 nM, ITK 36 nM, TEC 6.2 nM, TXK 8.9 nM

Potency Assay Off-Target:
High selectivity was noted against kinases with a comparable Cys (EGFR, ITK, JNK3). CC-292 was run ...

Potency
Cellular
In Vitro

BTK

Mode of Action: Covalent Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1124/jpet.113.203489

In Vivo Validations

Mouse
Dose: 50 mg/kg
Route of delivery: Oral
Organ of interest (O): spleen, joint
Target engagement assay: In the spleen, BTK occupancy was measured.

Reference: --

Orthogonal Probes def

CGI1746
GDC-0834

Chemical Information

Molecular Formula C22H22FN5O3
SMILEs C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
InChI InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)
Molecular weight 423.17 Da
AlogP 0.0
HBond acceptors 8
HBond donors 3
Atoms 53

References

Publications

Cross References

canSARChEMBLBindingDB

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews

by SERP
(on 22 May 2016)
Cellular Use Rating
This probe inhibits both BTK and EGFR, similar to ibrutinib. In cell based assays AVL-292 appears to have additional targets as it is cytotoxic to endothelial cells at 10 uM and active at 300 nM in...
by SERP
(on 2 Jun 2016)
Cellular Use Rating
In Model Organisms
AVL-292 is a covalent inhibitor of BTK (IC50apparent <0.5 nM). Selectivity was >1000-fold based on IC50 determination against a panel of 47 kinases, and in two larger kinome panels (386 and 205 kinases,...
by SERP
(on 12 Apr 2017)
Cellular Use Rating
In Model Organisms
AVL-292 is a covalent BTK inhibitor. Some selectivity data was provided demonstrating that the compound did inhibit other kinases under 100 nM (BMX, ITK, TEC, TXK) in a biochemical assay format. The...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria